Published in Blood Weekly, July 13th, 1998
HCS is a solution hybridization antibody capture assay for the detection and quantitation of cytomegalovirus (CMV) DNA in leukocytes.
To find whether HCS is sensitive enough to initiate and to monitor antiviral therapy after allogeneic stem cell transplantation, Holger Hebart and colleagues compared HCS to polymerase chain reaction (PCR) with whole blood and to rapid and conventional virus culture techniques for detection and quantitation of CMV in blood samples ("Evaluation of Murex CMV DNA Hybrid Capture Assay for Detection and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1998-07-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.